Decentralised, patient-centric, site-less, virtual, and digital clinical trials? From confusion to consensus

Publication date

2023-04

Authors

Trials@Home Consortium

Editors

Advisors

Supervisors

Document Type

Article

Collections

Open Access logo

License

cc_by

Abstract

There is increasing interest in clinical trials that use technologies and other innovative operational approaches to organise trial activities around trial participants instead of investigator sites. A range of terms has been introduced to refer to this operational clinical trial model, including virtual, digital, remote, and decentralised clinical trials (DCTs). However, this lack of standardised terminology can cause confusion over what a particular trial model entails and for what purposes it can be used, hampering discussions by stakeholders on its acceptability and suitability. Here, we review the different terms described in the scientific literature, advocate the consistent use of a unified term, ‘decentralised clinical trial,’ and provide a detailed definition of this term.

Keywords

decentralised clinical trial, direct-to-patient, patient-centric, remote clinical trial, telemedicine, virtual clinical trial, Pharmacology, Drug Discovery

Citation

Trials@Home Consortium 2023, 'Decentralised, patient-centric, site-less, virtual, and digital clinical trials? From confusion to consensus', Drug Discovery Today, vol. 28, no. 4, 103520. https://doi.org/10.1016/j.drudis.2023.103520